The stock's fall snapped a four-day winning streak.

Investing.com -- Immuneering Corp (NASDAQ:IMRX) stock surged 21.7% Monday after the clinical-stage oncology company announced ...

Market chatter about the frothiness of the AI market seems to be picking up as OpenAI CEO Sam Altman claims that he too sees ...

The 18-acre estate features a 14,200-square-foot residence with five bedrooms and eight bathrooms, as well as a guest house.

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is currently conducting a study titled ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is conducting a study ...

Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at ...

Shares of Immuneering rose after the company entered into a clinical supply agreement for Eli Lilly's olomorasib drug to support testing of Immuneering's proposed lung-cancer treatment. The stock was ...

Governor Mike Braun announces the sale of the former GM Stamping Plant property in Indianapolis to Elanco Animal Health for ...

The state reportedly sold the site on the southwest side for $27 million, as part of Elanco's plans for a new headquarters.

Eli Lilly and Company is making headlines with a staggering 170% price increase for its weight-loss drug, Mounjaro, in the UK ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...